Controllable 3D scaffold to grow more realistic human intestinal tissue

4D controllable extracellular matrix properties to guide iPSC-derived intestinal organoid fate and form

NIH-funded research Syracuse University · NIH-11320874

Researchers will change the physical support around lab-grown human intestinal cells so they develop into more mature, realistic gut tissue that could improve how intestinal diseases are studied.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSyracuse University NIH-funded
Lab location1 site (Syracuse, United States)
Project IDNIH-11320874 on NIH RePORTER

What this research studies

This project uses human iPSC-derived intestinal organoids—miniature gut tissues grown from human cells—to study how the surrounding matrix affects cell development. The team will create "blank-slate" biomaterials that precisely mimic extracellular matrix properties and then change those properties over time and in specific locations. By altering physical features like stiffness and structure as well as local signals, they aim to guide cell fate, maturation, and tissue shape. The goal is to make organoids that better resemble adult human intestine for research and future clinical translation.

Who could benefit from this research

Good fit: Adults with intestinal disorders could be ideal candidates for related future work if they are willing to donate tissue samples or join downstream clinical studies informed by improved organoid models.

Not a fit: Patients seeking immediate new therapies or symptom relief should not expect direct clinical benefit from this laboratory-focused project right now.

Why it matters

Potential benefit: If successful, the work could produce more mature, human-like intestinal organoids that improve disease modeling, drug testing, and the development of new gut treatments.

How similar studies have performed: Organoid approaches have already improved lab models of the human intestine, but using precisely controllable, time-varying extracellular matrices to drive maturation is a newer and less-tested strategy.

Where this research is happening

Syracuse, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.